Target intelligence / Profile preview

Escherichia coli O2 O-antigen (E. coli O2 O-antigen)

Target
E. coli O2 O-antigen
Molecular classification
Bacterial surface antigen, Polysaccharide, Lipopolysaccharide component
01

Overview

The Escherichia coli O2 O-antigen is a surface-exposed polysaccharide component of the lipopolysaccharide (LPS) molecule found on the outer membrane of specific E. coli serotypes (Poolman & Wacker, 2016). It is a critical member of the Extra-intestinal Pathogenic E. coli (ExPEC) group, which is frequently associated with severe infections such as urinary tract infections (UTIs), urosepsis, and neonatal meningitis (Frenck et al., 2019). The O-antigen acts as a major virulence factor by providing a physical barrier that protects the bacterium from host immune defenses, including complement-mediated killing and phagocytosis (Huttner et al., 2017). Due to its high prevalence in clinical isolates and its accessibility on the bacterial surface, the O2 O-antigen is a primary target for prophylactic vaccines, such as the multi-valent ExPEC conjugate vaccines like ExPEC9V (JNJ-64400141), and experimental monoclonal antibodies (Janssen, 2023). These therapeutic strategies aim to elicit or provide opsonophagocytic antibodies that facilitate the clearance of the pathogen by the host's immune system. Targeting this specific antigen allows for a precision medicine approach to preventing invasive E. coli disease caused by one of the most common serotypes globally.

Other names
O2 antigenE. coli O2 LPSO2-specific polysaccharideEscherichia coli serogroup O2 O-antigen
02

Mechanism of action

Active immunization to induce opsonophagocytic antibodies (OPAs) that bind the O2 antigen, facilitating phagocytosis and killing by neutrophils (Frenck et al., 2019).

03

Biological functions

Immune responseBacterial cell wall integrityComplement resistance
04

Disease associations

InfectionUrinary tract infectionUrosepsisBacteremia
05

Safety considerations

Serotype replacementEndotoxin-mediated toxicity (if not properly purified)Limited cross-reactivity with other E. coli serotypes
06

Interacting drugs

ExPEC9V (JNJ-64400141)

2 more in the full profile.

07

Biomarkers

E. coli O2 serotype identificationOpsonophagocytic activity (OPA) titers

Beyond the preview

Go deeper on Escherichia coli O2 O-antigen (E. coli O2 O-antigen).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Escherichia coli O2 O-antigen (E. coli O2 O-antigen).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call